quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:26:00·56d
PRRelease
Ginkgo Bioworks Holdings Inc. logo

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

DNA· Ginkgo Bioworks Holdings Inc.
Health Care
Original source

Companies

  • DNA
    Ginkgo Bioworks Holdings Inc.
    Health Care

Recent analyst ratings

  • May 15UpdateBTIG Research-
  • May 10UpdateWilliam Blair-
  • Nov 14UpdateRaymond James$2.50
  • Nov 9UpdateBTIG Research-
  • Jun 2UpdateGoldman$1.25
  • May 11UpdateWilliam Blair-

Related

  • INSIDER3d
    SEC Form 4 filed by Coen Steven P.
  • INSIDER9d
    SEC Form 4 filed by Coen Steven P.
  • INSIDER10d
    SEC Form 4 filed by Canton Barry
  • INSIDER10d
    SEC Form 4 filed by Shetty Reshma P.
  • INSIDER13d
    SEC Form 4 filed by Shetty Reshma P.
  • INSIDER13d
    SEC Form 4 filed by Canton Barry
  • INSIDER13d
    SEC Form 4 filed by Kelly Jason R
  • SEC16d
    Ginkgo Bioworks Holdings Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022